Literature DB >> 19327423

Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes.

George S Abela1, Kusai Aziz, Ameeth Vedre, Dorothy R Pathak, John D Talbott, Joyce Dejong.   

Abstract

Plaque disruption (PD) causes most acute cardiovascular events. Although cholesterol crystals (CCs) have been observed in plaques, their role in PD was unknown. However, cholesterol expands with crystallization tearing and perforating fibrous tissues. This study tested the hypothesis that CCs can damage plaques and intima, triggering PD, as observed in tissues prepared without ethanol solvents that dissolve CCs. Coronary arteries of patients who died of acute coronary syndrome (n = 19) and non-acute coronary syndrome causes (n = 12) and carotid plaques from patients with (n = 51) and without (n = 19) neurologic symptoms were studied. Samples were examined for CCs perforating the intima using light and scanning electron microscopy (SEM) with ethanol or vacuum dehydration. In addition, fresh unfixed carotid plaques were examined at 37 degrees C using confocal microscopy. Crystal content using SEM was scored from 0 to +3. SEM using vacuum dehydration had significantly higher crystal content compared with SEM using ethanol dehydration (+2.5 +/- 0.53 vs +0.25 +/- 0.46; p <0.0003), with enhanced detection of CC perforations. The presence of CCs using SEM and confocal microscopy was similar, suggesting that CC perforation can occur in vivo at 37 degrees C. All patients with acute coronary syndrome had perforating CCs, but none was present in patients without acute coronary syndrome (p = 0.0001). For all plaques, there were strong associations of CCs with PD, thrombus, symptoms (p <0.0001), and plaque size (p <0.02). Crystal content was an independent predictor of thrombus and symptoms. In conclusion, by avoiding ethanol in tissue preparation, CCs perforating the intima were shown to be associated with PD. Crystal content was significantly associated with clinical events, suggesting that cholesterol crystallization may have a role in PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19327423     DOI: 10.1016/j.amjcard.2008.12.019

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  52 in total

1.  Imaging mystery.

Authors:  Alexander P Rozin; Kohava Toledano; Doron Markovits; Alexandra Balbir-Gurman
Journal:  Rheumatol Int       Date:  2009-10-14       Impact factor: 2.631

2.  Label-free quantitative imaging of cholesterol in intact tissues by hyperspectral stimulated Raman scattering microscopy.

Authors:  Ping Wang; Junjie Li; Pu Wang; Chun-Rui Hu; Delong Zhang; Michael Sturek; Ji-Xin Cheng
Journal:  Angew Chem Int Ed Engl       Date:  2013-10-14       Impact factor: 15.336

Review 3.  Intravascular ultrasound and optical coherence tomography imaging of coronary atherosclerosis.

Authors:  Charis Costopoulos; Adam J Brown; Zhongzhao Teng; Stephen P Hoole; Nick E J West; Habib Samady; Martin R Bennett
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-08       Impact factor: 2.357

Review 4.  Symptomatic and asymptomatic carotid artery plaque.

Authors:  Majid M Mughal; Mohsin K Khan; J Kevin DeMarco; Arshad Majid; Fadi Shamoun; George S Abela
Journal:  Expert Rev Cardiovasc Ther       Date:  2011-10

5.  Relationship between cholesterol crystals and culprit lesion characteristics in patients with stable coronary artery disease: an optical coherence tomography study.

Authors:  Shunichi Nakamura; Shigenobu Inami; Koji Murai; Masamichi Takano; Hitoshi Takano; Kuniya Asai; Masahiro Yasutake; Wataru Shimizu; Kyoichi Mizuno
Journal:  Clin Res Cardiol       Date:  2014-08-03       Impact factor: 5.460

6.  Usefulness of pre- and post-stent optical frequency domain imaging findings in the prediction of periprocedural cardiac troponin elevation in patients with coronary artery disease.

Authors:  Kenichiro Otsuka; Kenei Shimada; Hirotoshi Ishikawa; Haruo Nakamura; Hisashi Katayama; Hisateru Takeda; Kohei Fujimoto; Noriaki Kasayuki; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2019-09-27       Impact factor: 2.037

7.  Synthesis of β-cyclodextrin conjugated superparamagnetic iron oxide nanoparticles for selective binding and detection of cholesterol crystals.

Authors:  Hongguang Li; Mohammad H El-Dakdouki; David C Zhu; George S Abela; Xuefei Huang
Journal:  Chem Commun (Camb)       Date:  2012-01-16       Impact factor: 6.222

8.  Statin therapy in the reduction of cardiovascular events in patients undergoing intermediate-risk noncardiac, nonvascular surgery.

Authors:  Manjunath G Raju; Ajay Pachika; Sujeeth R Punnam; Joseph C Gardiner; Mehdi H Shishehbor; Samir R Kapadia; George S Abela
Journal:  Clin Cardiol       Date:  2013-05-13       Impact factor: 2.882

9.  IL-22 is induced by S100/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1.

Authors:  Bijoy Chellan; Ling Yan; Timothy J Sontag; Catherine A Reardon; Marion A Hofmann Bowman
Journal:  J Lipid Res       Date:  2013-12-23       Impact factor: 5.922

10.  Plasmin promotes foam cell formation by increasing macrophage catabolism of aggregated low-density lipoprotein.

Authors:  Abigail S Haka; Inna Grosheva; Rajesh K Singh; Frederick R Maxfield
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-23       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.